Anti-RHOJ antibody [EPR28959-55],Abcam,AB317699

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Mouse

Application

WB, IP

Platform ID

BAB581987392

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-RHOJ antibody [EPR28959-55]
Cat. No.AB317699
HostRabbit
IsotypeIgG1
ReactivityHuman, Mouse
ApplicationWB, IP
ClonalityMonoclonal
Clone NumberEPR28959-55
Concentration0.514 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Plasma membrane-associated small GTPase specifically involved in angiogenesis (PubMed : 21628409, PubMed : 24434213, PubMed : 30158707). Required for endothelial cell migration during vascular development via its interaction with GLUL (PubMed : 30158707). Elicits the formation of F-actin-rich structures, thereby regulating endothelial cell migration (PubMed : 30158707). See full target information RHOJ

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.